Braxia Scientific (TSE:BRAX) has released an update.
Braxia Scientific, a medical research and telemedicine company, has announced that it will not meet the filing deadline for its annual financial statements and other required documents due to management changes, leading to an anticipated trading suspension. The company is actively seeking funding to cover audit expenses and aims to remedy the situation by September 15, 2024. Additionally, the company is in the process of replacing its recently resigned CFO and board member, Peter Rizakos.
For further insights into TSE:BRAX stock, check out TipRanks’ Stock Analysis page.
